Fairvalue-Calculator Fairvalue-Calculator
EN DE

Kuros Biosciences AG (CSBTF) Fair Value & Analysis

Healthcare · US · Market cap $1.0B

Price$26.00
Fair Value$3.08
Upside-88.2%
Quality82/100
Evidence: Medium Range $2.15 – $4.00

Fair value as of: Jun 24, 2026

Analysis

Kuros Biosciences AG (CSBTF) currently trades at $26.00, while our model-based Fair Value estimate is $3.08 — implying the stock looks roughly 88.2% overvalued today. We read business quality at 82/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABTT34) -84% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Kuros Biosciences AG (CSBTF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $3.08 versus a price of $26.00 — about −88% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CSBTF?
Our 21-model fair value for Kuros Biosciences AG is $3.08 (as of Jun 24, 2026), built from audited fundamentals. The current price is $26.00.
What is the quality score of CSBTF?
Kuros Biosciences AG has a Quality Score of 82/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.